Innovative Pipelines

As a pioneer and leading player in the development of innovative drugs located in China, Chipscreen Biosciences focuses on satisfying unmet clinical demand by developing first-in-class drugs based on unique molecular entities that are clinically effective for major diseases and enjoy global patent protection. Our efforts to date have yielded:

  • 2

    Approved Drug (4 indications)

  • 6

    Products In The Clinical Development Stage

  • 20+

    New Molecular Entities In The Preclinical Stage